हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Nehal Yemula, Vaclav Dostal, Michael Hornberger, Celina Dietrich
Background: Parkinson’s Disease (PD) is a progressive neurological condition characterized by degeneration of dopaminergic neurones within the basal ganglia. Accruing evidence from a variety of different studies suggests pathophysiological changes may first originate in the gut before they become apparent within the brain. The aim of the study was to investigate the prevalence of Gastrointestinal Tract symptoms (GIT) of early-stage PD patients. As such, this research aims to provide further supporting evidence to this limited field.
Methods: A single-center cross-sectional study conducted over 4 months which followed 12 participants with early-stage PD and 9 healthy controls. Participants completed a PD-specific gastrointestinal symptom questionnaire. Disease progression was evaluated through the Hoehn and Yahr Scale and Unified Parkinson’s Disease Rating part III (UPDRS) motor score.
Results: Tenesmus (83.3%), constipation (58.3%) and abdominal bloating (58.3%) were the most experienced symptoms for early-stage PD patients. Tenesmus (p=0.006) and constipation (p=0.03) also showed statistically significant differences between PD and control groups. However, there was no significant relationship between the prevalence of gut symptoms and UPDRS motor score (r=0.278, p=0.38).
Conclusion: A variety of gastrointestinal symptoms, particularly lower gastrointestinal tract, were prevalent in early-stage disease. There was no apparent relationship between the prevalence of gastrointestinal tract symptoms and the UPDRS motor score. A well designed, appropriate gastrointestinal tract questionnaire to screen for symptoms in early-stage disease may be of use in future clinical practice.